Oxidative stress and adipocyte biology: Focus on the role of AGEs

Oxidative Medicine and Cellular Longevity

Volumn 2015, Issue , 2015, Pages

  Boyer, Florence ^a   Vidot, Jennifer Baraka ^a   Dubourg, Alexis Guerin ^a   Rondeau, Philippe ^a   Essop, M Faadiel ^b   Bourdon, Emmanuel ^a  

^a UNIVERSITÉ DE LA RÉUNION   (France)

^b STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

MOLECULAR WEIGHT; NUTRITION; PATHOLOGY;

ADIPOCYTES; ADIPOSE TISSUE; ADVANCED GLYCATION END PRODUCTS; BIOLOGICAL COMPOUNDS; GLYCATED ALBUMINS; OXIDATIVE DAMAGE; OXIDATIVE MODIFICATION; PATHOPHYSIOLOGY;

TISSUE;

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; GLYCOSYLATED ALBUMIN; LACTOYLGLUTATHIONE LYASE;

ADIPOCYTE; ADIPOSE TISSUE; CELL INTERACTION; CYTOLOGY; DIABETES MELLITUS; DISEASE COURSE; ENDOCYTOSIS; EX VIVO STUDY; GLYCATION; HUMAN; HYPERGLYCEMIA; IN VITRO STUDY; INFLAMMATION; INSULIN SENSITIVITY; NONHUMAN; OXIDATIVE STRESS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVIEW; METABOLISM; PATHOLOGY;

ADIPOCYTES; ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; DIABETES MELLITUS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; HYPERGLYCEMIA; LACTOYLGLUTATHIONE LYASE; OXIDATIVE STRESS;

EID: 84927145399     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2015/534873     Document Type: Review

References (71)

1. D. R. Whiting, L. Guariguata, C. Weil, and J. Shaw, "IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030, " Diabetes Research and Clinical Practice, vol. 94, no. 3, pp. 311-321, 2011.
2. S. E. Shoelson, J. Lee, and A. B. Goldfine, "Inflammation and insulin resistance, "The Journal of Clinical Investigation, vol. 116, no. 7, pp. 1793-1801, 2006.
3. P. Trayhurn, "Hypoxia and adipose tissue function and dysfunction in obesity, " Physiological Reviews, vol. 93, no. 1, pp. 1-21, 2013.
4. P. G. Kopelman, "Obesity as a medical problem, " Nature, vol. 404, no. 6778, pp. 635-643, 2000.
5. J. -Y. Youn, K. L. Siu, H. E. Lob, H. Itani, D. G. Harrison, and H. Cai, "Role of vascular oxidative stress in obesity and metabolic syndrome, " Diabetes, vol. 63, no. 7, pp. 2344-2355, 2014.
6. S. Furukawa, T. Fujita, M. Shimabukuro et al., "Increased oxidative stress in obesity and its impact onmetabolic syndrome, "The Journal of Clinical Investigation, vol. 114, no. 12, pp. 1752-1761, 2004.
7. R. F. Mapanga, D. Joseph, B. Symington et al., "Detrimental effects of acute hyperglycaemia on the rat heart, " Acta Physiologica (Oxf), vol. 210, no. 3, pp. 546-564, 2014.
8. D. Joseph, C. Kimar, B. Symington, R. Milne, and M. F. Essop, "The detrimental effects of acute hyperglycemia on myocardial glucose uptake, " Life Sciences, vol. 105, no. 1-2, pp. 31-42, 2014.
9. F. Giacco and M. Brownlee, "Oxidative stress and diabetic complications, " Circulation Research, vol. 107, no. 9, pp. 1058-1070, 2010.
10. C. Ott, K. Jacobs, E. Haucke, A. Navarrete Santos, T. Grune, and A. Simm, "Role of advanced glycation end products in cellular signaling, " Redox Biology, vol. 2, no. 1, pp. 411-429, 2014.
11. M. Roche, P. Rondeau, N. R. Singh, E. Tarnus, and E. Bourdon, "The antioxidant properties of serum albumin, " FEBS Letters, vol. 582, no. 13, pp. 1783-1787, 2008.
12. P. Rondeau and E. Bourdon, "The glycation of albumin: structural and functional impacts, " Biochimie, vol. 93, no. 4, pp. 645-658, 2011.
13. K. H. Gaens, C. D. Stehouwer, and C. G. Schalkwijk, "Advanced glycation endproducts and its receptor for advanced glycation endproducts in obesity, " Current Opinion in Lipidology, vol. 24, no. 1, pp. 4-11, 2013.
14. S. Horiuchi, Y. Sakamoto, and M. Sakai, "Scavenger receptors for oxidized and glycated proteins, " Amino Acids, vol. 25, no. 3-4, pp. 283-292, 2003.
15. A. Kuniyasu, N. Ohgami, S. Hayashi, A. Miyazaki, S. Horiuchi, and H. Nakayama, "CD36-mediated endocytic uptake of advanced glycation end products (AGE) in mouse 3T3-L1 and human subcutaneous adipocytes, " FEBS Letters, vol. 537, no. 1-3, pp. 85-90, 2003.
16. M. P. Cohen, "Clinical, pathophysiological and structure/function consequences ofmodification of albumin by Amadoriglucose adducts, " Biochimica et Biophysica Acta-General Subjects, vol. 1830, no. 12, pp. 5480-5485, 2013.
17. S. Pennathur and J. W. Heinecke, "Mechanisms for oxidative stress in diabetic cardiovascular disease, " Antioxidants and Redox Signaling, vol. 9, no. 7, pp. 955-969, 2007.
18. H. Vlassara and G. E. Striker, "AGE restriction in diabetes mellitus: a paradigm shift, " Nature Reviews Endocrinology, vol. 7, no. 9, pp. 526-539, 2011.
19. N. B. Ruderman, J. R. Williamson, and M. Brownlee, "Glucose and diabetic vascular disease, " The FASEB Journal, vol. 6, no. 11, pp. 2905-2914, 1992.
20. A. Stirban, T. Gawlowski, and M. Roden, "Vascular effects of advanced glycation endproducts: clinical effects and molecular mechanisms, " Molecular Metabolism, vol. 3, no. 2, pp. 94-108, 2014.
21. S. Radjei, B. Friguet, C. Nizard, and I. Petropoulos, "Prevention of dicarbonyl-mediated advanced glycation by glyoxalases: implication in skin aging, " Biochemical Society Transactions, vol. 42, no. 2, pp. 518-522, 2014.
22. P. J. Thornalley, A. Langborg, and H. S. Minhas, "Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose, " Biochemical Journal, vol. 344, part 1, pp. 109-116, 1999.
23. N. Ohgami, R. Nagai, M. Ikemoto et al., "CD36, a member of class B scavenger receptor family, is a receptor for advanced glycation end products, " Annals of the New York Academy of Sciences, vol. 947, pp. 350-355, 2001.
24. P. J. Thornalley, "Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs, " Cellular and Molecular Biology, vol. 44, no. 7, pp. 1013-1023, 1998.
25. C. Cerami, H. Founds, I. Nicholl et al., "Tobacco smoke is a source of toxic reactive glycation products, " Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 25, pp. 13915-13920, 1997.
26. A. Guerin-Dubourg, A. Catan, E. Bourdon, and P. Rondeau, "Structural modifications of human albumin in diabetes, " Diabetes and Metabolism, vol. 38, no. 2, pp. 171-178, 2012.
27. J. Baraka-Vidot, A. Guerin-Dubourg, F. Dubois, B. Payet, E. Bourdon, and P. Rondeau, "New insights into deleterious impacts of in vivo glycation on albumin antioxidant activities, " Biochimica et Biophysica Acta, vol. 1830, no. 6, pp. 3532-3541, 2013.
28. J. Baraka-Vidot, A. Guerin-Dubourg, E. Bourdon, and P. Rondeau, "Impaired drug-binding capacities of in vitro and in vivo glycated albumin, " Biochimie, vol. 94, no. 9, pp. 1960-1967, 2012.
29. N. C. Chilelli, S. Burlina, and A. Lapolla, "AGEs, rather than hyperglycemia, are responsible formicrovascular complications in diabetes: a 'glycoxidation-centric' point of view, " Nutrition, Metabolism & Cardiovascular Diseases, vol. 23, no. 10, pp. 913-919, 2013.
30. Y. Miki, H. Dambara, Y. Tachibana, K. Hirano, M. Konishi, and M. Beppu, "Macrophage recognition of toxic advanced glycosylation end products through the macrophage surfacereceptor nucleolin, " Biological and Pharmaceutical Bulletin, vol. 37, no. 4, pp. 588-596, 2014.
31. M. Freeman, Y. Ekkel, L. Rohrer et al., "Expression of type I and type II bovine scavenger receptors in Chinese hamster ovary cells: lipid droplet accumulation and nonreciprocal cross competition by acetylated and oxidized low density lipoprotein, " Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 11, pp. 4931-4935, 1991.
32. "obesity, " in Merriam Webster Dictionnary, 2014, http://www.merriam-webster.com/dictionary/obesity.
33. M. Lafontan, "Fat cells: afferent and efferent messages define new approaches to treat obesity, " Annual Review of Pharmacology and Toxicology, vol. 45, pp. 119-146, 2005.
34. G. S. Hotamisligil, "Inflammation and metabolic disorders, " Nature, vol. 444, no. 7121, pp. 860-867, 2006.
35. A. P. Rocchini, "Childhood obesity and a diabetes epidemic, " The New England Journal of Medicine, vol. 346, no. 11, pp. 854-855, 2002.
36. B. Balkau, J. E. Deanfield, J. -P. Després et al., "International day for the evaluation of abdominal obesity (IDEA):Astudy of waist circumference, cardiovascular disease, and diabetes mellitus in 168 000 primary care patients in 63 countries, " Circulation, vol. 116, no. 17, pp. 1942-1951, 2007.
37. A. B. Mayerson, R. S. Hundal, S. Dufour et al., "The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes, " Diabetes, vol. 51, no. 3, pp. 797-802, 2002.
38. R. Rahimi, S. Nikfar, B. Larijani, and M. Abdollahi, "Areview on the role of antioxidants in the management of diabetes and its complications, " Biomedicine and Pharmacotherapy, vol. 59, no. 7, pp. 365-373, 2005.
39. P. Arner, "The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones, " Trends in Endocrinology and Metabolism, vol. 14, no. 3, pp. 137-145, 2003.
40. D. Thompson, F. Karpe, M. Lafontan, and K. Frayn, "Physical activity and exercise in the regulation of human adipose tissue physiology, " Physiological Reviews, vol. 92, no. 1, pp. 157-191, 2012.
41. E. Oliveros, V. K. Somers, O. Sochor, K. Goel, and F. Lopez-Jimenez, "The concept of normal weight obesity, " Progress in Cardiovascular Diseases, vol. 56, no. 4, pp. 426-433, 2014.
42. M. Lafontan, "Historical perspectives in fat cell biology: the fat cell as a model for the investigation of hormonal and metabolic pathways, "The American Journal of Physiology-Cell Physiology, vol. 302, no. 2, pp. C327-C359, 2012.
43. M. Lafontan, "Adipose tissue and adipocyte dysregulation, " Diabetes and Metabolism, vol. 40, no. 1, pp. 16-28, 2014.
44. K. E. Wellen and G. S. Hotamisligil, "Inflammation, stress, and diabetes, "The Journal of Clinical Investigation, vol. 115, no. 5, pp. 1111-1119, 2005.
45. N. Hosogai, A. Fukuhara, K. Oshima et al., "Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation, " Diabetes, vol. 56, no. 4, pp. 901-911, 2007.
46. M. F. Gregor and G. S. Hotamisligil, "Thematic review series: adipocyte biology. Adipocyte stress: the endoplasmic reticulum and metabolic disease, " Journal of Lipid Research, vol. 48, no. 9, pp. 1905-1914, 2007.
47. F. Tourniaire, B. Romier-Crouzet, J. H. Lee et al., "Chemokine expression in inflamed adipose tissue ismainlymediated byNF-κB, " PLoS ONE, vol. 8, no. 6, Article ID e66515, 2013.
48. M. Fukushima, Y. Okamoto, H. Katsumata et al., "Growth hormone ameliorates adipose dysfunction during oxidative stress and inflammation and improves glucose tolerance in obese mice, " Hormone and Metabolic Research, vol. 46, no. 09, pp. 656-662, 2014.
49. B. I. Frohnert, E. K. Long, W. S. Hahn, and D. A. Bernlohr, "Glutathionylated lipid aldehydes are products of adipocyte oxidative stress and activators of macrophage inflammation, " Diabetes, vol. 63, no. 1, pp. 89-100, 2014.
50. A. Priyanka, V. M. Nisha, S. S. Anusree, and K. G. Raghu, "Bilobalide attenuates hypoxia induced oxidative stress, inflammation, and mitochondrial dysfunctions in 3T3-L1 adipocytes via its antioxidant potential, " Free Radical Research, vol. 48, no. 10, pp. 1206-1217, 2014.
51. A. Fujiya, H. Nagasaki, Y. Seino et al., "The role of S100B in the interaction between adipocytes andmacrophages, " Obesity, vol. 22, no. 2, pp. 371-379, 2014.
52. A. Priyanka, S. S. Anusree, V. M. Nisha, and K. G. Raghu, "Curcumin improves hypoxia induced dysfunctions in 3T3-L1 adipocytes by protecting mitochondria and down regulating inflammation, " BioFactors, vol. 40, no. 5, pp. 513-523, 2014.
53. P. Baret, A. Septembre-Malaterre, M. Rigoulet et al., "Dietary polyphenols preconditioning protects 3T3-L1 preadipocytes from mitochondrial alterations induced by oxidative stress, " International Journal of Biochemistry and Cell Biology, vol. 45, no. 1, pp. 167-174, 2013.
54. F. S. Lira, J. C. Rosa, G. D. Pimentel et al., "Both adiponectin and interleukin-10 inhibit LPS-induced activation of the NF-κB pathway in 3T3-L1 adipocytes, " Cytokine, vol. 57, no. 1, pp. 98-106, 2012.
55. Y. Lin, A. H. Berg, P. Iyengar et al., "The hyperglycemiainduced inflammatory response in adipocytes: the role of reactive oxygen species, " The Journal of Biological Chemistry, vol. 280, no. 6, pp. 4617-4626, 2005.
56. Y. Uchida, K. -I. Ohba, T. Yoshioka, K. Irie, T. Muraki, and Y. Maru, "Cellular carbonyl stress enhances the expression of plasminogen activator inhibitor-1 in rat white adipocytes via reactive oxygen species-dependent pathway, " Journal of Biological Chemistry, vol. 279, no. 6, pp. 4075-4083, 2004.
57. C. -Y. Chen, A. M. Abell, Y. S. Moon, and K. -H. Kim, "An advanced glycation end product (AGE)-receptor for AGEs (RAGE) axis restores adipogenic potential of senescent preadipocytes through modulation of p53 protein function, " Journal of Biological Chemistry, vol. 287, no. 53, pp. 44498-44507, 2012.
58. S. Chesne, P. Rondeau, S. Armenta, and E. Bourdon, "Effects of oxidative modifications induced by the glycation of bovine serum albumin on its structure and on cultured adipose cells, " Biochimie, vol. 88, no. 10, pp. 1467-1477, 2006.
59. N. R. Singh, P. Rondeau, L. Hoareau, and E. Bourdon, "Identification of preferential protein targets for carbonylation in human mature adipocytes treatedwith native or glycated albumin, " Free Radical Research, vol. 41, no. 10, pp. 1078-1088, 2007.
60. N. R. Singh, P. Rondeau, and E. Bourdon, "Identification of upregulated low molecular weight proteins in human adipocytes treated with glycoxidized albumin, " The Open Obesity Journal, vol. 2, no. 1, pp. 110-115, 2009.
61. Y. Unno, M. Sakai, Y. -I. Sakamoto et al., "Glycolaldehydemodified bovine serum albumin downregulates leptin expression in mouse adipocytes via a CD36-mediated pathway, " Annals of the New York Academy of Sciences, vol. 1043, pp. 696-701, 2005.
62. S. Horiuchi, Y. Unno, H. Usui et al., "Pathological roles of advanced glycation end product receptors SR-A and CD36, " Annals of the New York Academy of Sciences, vol. 1043, pp. 671-675, 2005.
63. S. Maeda, T. Matsui, M. Takeuchi, and S. -I. Yamagishi, "Pigment epithelium-derived factor (PEDF) blocks advanced glycation end products (AGEs)-RAGE-induced suppression of adiponectin mRNA level in adipocytes by inhibiting NADPH oxidase-mediated oxidative stress generation, " International Journal of Cardiology, vol. 152, no. 3, pp. 408-410, 2011.
64. N. Frizzell, M. Lima, and J. W. Baynes, "Succination of proteins in diabetes, " Free Radical Research, vol. 45, no. 1, pp. 101-109, 2011.
65. N. Frizzell, M. Rajesh, M. J. Jepson et al., "Succination of thiol groups in adipose tissue proteins in diabetes: succination inhibits polymerization and secretion of adiponectin, " The Journal of Biological Chemistry, vol. 284, no. 38, pp. 25772-25781, 2009.
66. H. Wassef, L. Bernier, J. Davignon, and J. S. Conn, "Synthesis and secretion of apoC-I and apoE during maturation of human SW872 liposarcoma cells, " Journal of Nutrition, vol. 134, no. 11, pp. 2935-2941, 2004.
67. L. Izem and R. E. Morton, "Possible role for intracellular cholesteryl ester transfer protein in adipocyte lipid metabolism and storage, "The Journal of Biological Chemistry, vol. 282, no. 30, pp. 21856-21865, 2007.
68. G. Vassiliou and R. McPherson, "Role of cholesteryl ester transfer protein in selective uptake of high density lipoprotein cholesteryl esters by adipocytes, " Journal of Lipid Research, vol. 45, no. 9, pp. 1683-1693, 2004.
69. D. Ramful, E. Tarnus, P. Rondeau, C. R. Da Silva, T. Bahorun, and E. Bourdon, "Citrus fruit extracts reduce advanced glycation end products (AGEs)-and H2O2-induced oxidative stress in human adipocytes, " Journal of Agricultural and Food Chemistry, vol. 58, no. 20, pp. 11119-11129, 2010.
70. M. Roche, E. Tarnus, P. Rondeau, and E. Bourdon, "Effects of nutritional antioxidants on AAPH-or AGEs-induced oxidative stress in human SW872 liposarcoma cells, " Cell Biology and Toxicology, vol. 25, no. 6, pp. 635-644, 2009.
71. O. Brouwers, P. M. Niessen, I. Ferreira et al., "Overexpression of glyoxalase-I reduces hyperglycemia-induced levels of advanced glycation end products and oxidative stress in diabetic rats, " Journal of Biological Chemistry, vol. 286, no. 2, pp. 1374-1380, 2011.